The cost of not covering payment of treatment for Depressive Disorders
AbstractIn 2016 I was diagnosed with major recurrent depressive disorder (F33.2). I used Citalopram and various evidence based nonpharmacological treatments (psycho-therapy, mindfulness, exercise and an eating plan reducing my weight from 88kg [BMI = 27.8] to 78 kg [BMI = 24.6]). However my symptoms continued unabatedly, especially insomnia, daily suicidal thinking, poor concentration and decision making. Changing treatment to agomelatine (Valdoxan®) was equally unsuccessful. In mid-2017 I then changed to bupropion (Wellbutrin®) and a low dose of amitriptyline (12.5 mg) with marked improvement within 48 hours. Within a week I had positive thoughts, slept well and my cognition was back to normal.
Letters to the editor
By submitting manuscripts to SAFP, authors of original articles are assigning copyright to the South African Academy of Family Physicians. Copyright of review articles are assigned to the Publisher, Medpharm Publications (Pty) Ltd, unless otherwise specified. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAFP for educational and research purposes without obtaining permission.